Amedisys Net Total Equity Issued/Repurchased 2010-2024 | AMED
Amedisys net total equity issued/repurchased from 2010 to 2024. Net total equity issued/repurchased can be defined as the sum of all preferred and common equity transactions regarding a company's own stock.
Amedisys Annual Net Total Equity Issued/Repurchased
(Millions of US $) |
| 2024 |
$-6 |
| 2023 |
$-4 |
| 2022 |
$-19 |
| 2021 |
$-111 |
| 2020 |
$-45 |
| 2019 |
$-3 |
| 2018 |
$-180 |
| 2017 |
$0 |
| 2016 |
$-10 |
| 2015 |
$-2 |
| 2014 |
$3 |
| 2013 |
$3 |
| 2012 |
$4 |
| 2011 |
$5 |
| 2010 |
$-4 |
| 2009 |
$9 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$3.011B |
$2.348B |
|
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
|
